PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that it has selected Getwell Life Sciences, based in New Delhi, to distribute Zila’s ViziLite® Plus with TBlue®, a proprietary oral cancer screening product, throughout India. Financial terms of the agreement were not disclosed.
